Lombard Odier Asset Management (Switzerland)’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-88,072
| Closed | -$4.91M | – | 370 |
|
|
2023
Q1 | $4.91M | Buy |
88,072
+3,596
| +4% | +$201K | 0.43% | 64 |
|
|
2022
Q4 | $3.08M | Buy |
84,476
+20,412
| +32% | +$744K | 0.25% | 93 |
|
|
2022
Q3 | $1.83M | Sell |
64,064
-11,530
| -15% | -$328K | 0.15% | 120 |
|
|
2022
Q2 | $3.42M | Sell |
75,594
-4,682
| -6% | -$212K | 0.29% | 83 |
|
|
2022
Q1 | $6.11M | Sell |
80,276
-75,676
| -49% | -$5.76M | 0.48% | 58 |
|
|
2021
Q4 | $23.2M | Buy |
155,952
+13,180
| +9% | +$1.96M | 1.48% | 27 |
|
|
2021
Q3 | $20.8M | Buy |
142,772
+39,858
| +39% | +$5.8M | 1.29% | 35 |
|
|
2021
Q2 | $20.2M | Buy |
102,914
+3,853
| +4% | +$755K | 1.02% | 44 |
|
|
2021
Q1 | $17.9M | Buy |
+99,061
| New | +$17.9M | 1.19% | 29 |
|